Aspiriant LLC’s Vanguard Ultra-Short Bond ETF VUSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.26M Sell
85,605
-3,106
-4% -$155K 0.12% 76
2025
Q4
$4.42M Buy
88,711
+1,798
+2% +$89.7K 0.13% 75
2025
Q3
$4.35M Buy
86,913
+23,987
+38% +$1.2M 0.13% 72
2025
Q2
$3.14M Buy
62,926
+15,081
+32% +$749K 0.1% 83
2025
Q1
$2.39M Buy
47,845
+12,655
+36% +$629K 0.08% 87
2024
Q4
$1.75M Buy
35,190
+228
+0.7% +$11.3K 0.06% 104
2024
Q3
$1.75M Buy
34,962
+1,840
+6% +$91.4K 0.07% 103
2024
Q2
$1.64M Buy
33,122
+2,752
+9% +$136K 0.07% 100
2024
Q1
$1.5M Sell
30,370
-4,775
-14% -$236K 0.06% 113
2023
Q4
$1.74M Sell
35,145
-1,926
-5% -$94.8K 0.08% 102
2023
Q3
$1.82M Buy
37,071
+8,553
+30% +$420K 0.09% 95
2023
Q2
$1.4M Sell
28,518
-11,573
-29% -$569K 0.07% 104
2023
Q1
$1.97M Buy
40,091
+9,693
+32% +$476K 0.1% 88
2022
Q4
$1.49M Buy
30,398
+11,285
+59% +$552K 0.08% 100
2022
Q3
$935K Buy
19,113
+11,608
+155% +$571K 0.05% 126
2022
Q2
$369K Buy
+7,505
New +$370K 0.02% 194

Other funds holding VUSB

Aspiriant LLC's VUSB Position: Q1 2026 in Review

Aspiriant LLC reduced its Vanguard Ultra-Short Bond ETF (VUSB) stake by 3.5% in Q1 2026, selling an estimated $155K and leaving 85,605 shares worth $4.26M. The position accounts for 0.12% of the portfolio, ranked #76.

Aspiriant LLC first reported a position in VUSB in Q2 2022 and has held it in 16 quarters since. The position peaked at $4.42M in Q4 2025. 470 funds tracked by Wall St. Rank hold VUSB as of Q1 2026.

  • Aspiriant LLC held 85,605 shares of Vanguard Ultra-Short Bond ETF worth $4.26M as of Q1 2026.
  • Aspiriant LLC sold 3,106 Vanguard Ultra-Short Bond ETF shares in Q1 2026, an estimated $155K.
  • Vanguard Ultra-Short Bond ETF made up 0.12% of Aspiriant LLC's portfolio in Q1 2026, its #76 holding.
  • Aspiriant LLC first reported a position in Vanguard Ultra-Short Bond ETF in Q2 2022 and has held it in 16 quarters since.
  • Aspiriant LLC's Vanguard Ultra-Short Bond ETF position peaked at $4.42M in Q4 2025.
  • 470 funds tracked by Wall St. Rank held Vanguard Ultra-Short Bond ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.